Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Assessing a biomarker platform for stratifying indeterminate pulmonary nodules, protocol for the SPOT IT randomized trial.

Trials·2026
Same author

Goal Concordance in the Advancing Symptom Alleviation with Palliative Treatment Clinical Trial of a Nurse and Social Worker Palliative Telecare Team Intervention.

Journal of palliative medicine·2026
Same author

Integrating Deep Learning of Low-Dose CT Imaging With Clinical Data for Lung Cancer Risk Prediction.

Chest·2026
Same author

<i>Letter:</i> Measuring Goal Concordance Using a Likert Scale in the ADAPT Clinical Trial.

Journal of palliative medicine·2026
Same author

Chronic Respiratory Diseases and Lung Cancer Risk.

Archivos de bronconeumologia·2025

Related Experiment Video

Updated: Dec 24, 2025

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.4K

Quantifying the incremental value of deep learning: Application to lung nodule detection.

Theodore Warsavage1, Fuyong Xing1, Anna E Barón1

  • 1Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America.

Plos One
|April 15, 2020
PubMed
Summary

We developed a machine learning model for lung cancer research to assess its incremental value. The model improved predictions using patient characteristics but showed variable performance on different datasets.

More Related Videos

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.9K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

699

Related Experiment Videos

Last Updated: Dec 24, 2025

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.4K
Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

1.9K
Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy
05:24

Multifractal Spectrum Analysis for Assessing Pulmonary Nodule Malignancy

Published on: January 10, 2025

699

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Machine learning (ML) models show promise in prediction tasks but their implementation and value assessment are in early development.
  • Existing methods often compare ML models directly to traditional approaches, lacking a framework to quantify added value.
  • This study introduces an incremental value framework to evaluate ML model performance in lung cancer research.

Observation:

  • A novel ML model was developed to identify and classify lung nodules using data from The Cancer Imaging Archive (TCIA).
  • The model's incremental value was assessed by integrating it with existing lung cancer risk prediction models.
  • External datasets were utilized for robust validation of the ML model's performance.

Findings:

  • The ML image model enhanced existing risk prediction models that relied solely on patient characteristics.
  • The model's improvement over prediction models incorporating nodule features was inconclusive.
  • Variable performance across different validation datasets highlighted challenges in achieving population generalization with ML models.

Implications:

  • This work provides a framework for evaluating the true incremental value of ML models in clinical research.
  • The findings suggest that while ML can augment traditional models, careful validation is needed for broad applicability.
  • Further research is warranted to address generalization challenges and optimize ML model performance in diverse populations for lung cancer detection.